EUVIMEDEUVIMED entdecken
Crossref

Discovery of novel oleanolic acid glycoside derivatives targeting PTP1B/PI3K/AKT signaling pathway for the treatment of breast cancer

Xiaoping Song, Lina Wang, Yao Liu, Kefan Xu, Panpan Cai, Jinqiu Liu, Qingchao Liu, Daidi Fan

Bioorganic Chemistry · 2025-04 · 157 · 108296

DOI: 10.1016/j.bioorg.2025.108296 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic Chemistry, 2025-04. Verfasst von Xiaoping Song und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Engineering, School of Chemical Engineering, Northwest University, 229 Taibai North Road, Xi'an 710069, PR China. Hauptthemen laut MEDLINE: Protein Tyrosine Phosphatase, Non-Receptor Type 1, Oleanolic Acid, Proto-Oncogene Proteins c-akt, Breast Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shaanxi Science and Technology Association, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Protein tyrosine phosphatase 1B (PTP1B) has been identified as a key drug target for anti-tumor drug development. Oleanolic acid (OA) has been proved to be an inhibitor of PTP1B, but its poor water solubility, low bioavailability and poor activity in vivo limit its clinical efficacy. In this study, a total of 47 new OA derivatives including heteroatom derivatives, ester derivatives, amino substitution derivatives and Schiff base derivatives were designed and synthesized. Among them, OA-Br-1 had stronger inhibition and selectivity on PTP1B than OA, with IC50 value of 7.08 ± 5.05 μM for PTP1B and 222.28 ± 0.11 μM for TCPTP. In addition, OA-Br-1 significantly inhibited the proliferation and induced apoptosis of breast cancer cells, and in vivo nude mice experiments also showed that OA-Br-1 could inhibit the growth of breast tumors. Then network pharmacology was used to predict the targets of OA-Br-1, and the PPI network map between compound - breast cancer - target was constructed. The results showed that the probability value of PTPN1 ranked first among all predicted targets, which was consistent with the results of enzyme activity experiments in vitro. The enrichment results of KEGG pathway and GO functional annotation analysis showed that the effect of OA-Br-1 on breast cancer was significantly correlated with the PI3K/AKT pathway. Subsequent Western Blot results also proved that OA-Br-1 could significantly inhibit the expression of PTP1B, p-PI3K and p-AKT, indicating that OA-Br-1 played an anti-breast cancer role through the PTP1B/PI3K/AKT signaling pathway. Collectively, these findings identify OA-Br-1 as a promising PTP1B inhibitor for breast cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein Tyrosine Phosphatase, Non-Receptor Type 1Oleanolic AcidProto-Oncogene Proteins c-aktBreast NeoplasmsAntineoplastic AgentsPhosphatidylinositol 3-KinasesSignal TransductionCell ProliferationMice, NudeHumansFemaleAnimalsMiceStructure-Activity RelationshipMolecular StructureDrug Screening Assays, AntitumorGlycosidesDose-Response Relationship, DrugDrug DiscoveryApoptosisEnzyme InhibitorsMice, Inbred BALB C

Stichwörter der Autor:innen

Breast cancerOleanolic acidPI3K/AKTPTP1B

Substanzen

Protein Tyrosine Phosphatase, Non-Receptor Type 1Oleanolic AcidProto-Oncogene Proteins c-aktPTPN1 protein, humanAntineoplastic AgentsPhosphatidylinositol 3-KinasesGlycosidesEnzyme Inhibitors

Autor:innen und Institutionen

  • Department of Pharmaceutical Engineering, School of Chemical Engineering, Northwest University, 229 Taibai North Road, Xi'an 710069, PR China.
  • Technological Institute of Materials & Energy Science (TIMES), Key Laboratory of Liquid Crystal Polymers based Flexible Display Technology in National Petroleum and Chemical Industry, Xi'an Key Laboratory of Advanced Ph…
  • Department of Pharmaceutical Engineering, School of Chemical Engineering, Northwest University, 229 Taibai North Road, Xi'an 710069, PR China; Biotech. & Biomed. Research Institute, Northwest University, 229 Taibai Nort…

Förderung

  • National Natural Science Foundation of China
  • Shaanxi Science and Technology Association
  • National Key Research and Development Program of China
  • Key Technologies Research and Development Program

Zitieren

APA

Song, X., Wang, L., Liu, Y., Xu, K., Cai, P., Liu, J., Liu, Q., & Fan, D. (2025). Discovery of novel oleanolic acid glycoside derivatives targeting PTP1B/PI3K/AKT signaling pathway for the treatment of breast cancer. Bioorganic Chemistry, 157, 108296. https://doi.org/10.1016/j.bioorg.2025.108296

Vancouver

Song X, Wang L, Liu Y, Xu K, Cai P, Liu J, et al. Discovery of novel oleanolic acid glycoside derivatives targeting PTP1B/PI3K/AKT signaling pathway for the treatment of breast cancer. Bioorganic Chemistry. 2025;157:108296. doi:10.1016/j.bioorg.2025.108296

BibTeX
@article{Song2025,
  author = {Song, Xiaoping and Wang, Lina and Liu, Yao and Xu, Kefan and Cai, Panpan and Liu, Jinqiu and Liu, Qingchao and Fan, Daidi},
  title = {Discovery of novel oleanolic acid glycoside derivatives targeting PTP1B/PI3K/AKT signaling pathway for the treatment of breast cancer},
  journal = {Bioorganic Chemistry},
  year = {2025},
  volume = {157},
  pages = {108296},
  doi = {10.1016/j.bioorg.2025.108296}
}
Kostenlos starten →